News + Filings Transactions
|
CHAMPSI FARAH
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/26/2021 | Population Health Investment Co., Inc. | | Other (acquisition) | Class B Ordinary Shares | 43.1k | $250.00 | $10.8M | | 01/26/2021 |
| 06/20/2017 | Kite Pharma, Inc. | KITE | Grant | Common Stock | 2.4k | $0.00 | $0 | | 06/20/2017 |
| 06/20/2017 | Kite Pharma, Inc. | KITE | Grant | Director Stock Option (Right to Buy) | 8.8k | $91.21 | $803.6k | | 06/20/2017 |
| 06/16/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 5.4k | $88.11 | $480.2k | See Footnote | 06/14/2017 |
| 06/14/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 15k | $90.40 | $1.4M | | 06/14/2017 |
| 04/28/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 2.6k | $82.59 | $216.1k | See Footnote | 04/27/2017 |
| 04/27/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 16.6k | $82.77 | $1.4M | See Footnote | 04/27/2017 |
| 04/26/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 200 | $83.06 | $16.6k | See Footnote | 04/24/2017 |
| 04/26/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 51.1k | $82.72 | $4.2M | See Footnote | 04/24/2017 |
| 04/25/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 15.3k | $83.29 | $1.3M | See Footnote | 04/24/2017 |
| 04/25/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 31.5k | $82.56 | $2.6M | See Footnote | 04/24/2017 |
| 04/24/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 25.8k | $82.34 | $2.1M | See Footnote | 04/24/2017 |
| 04/17/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 100 | $83.06 | $8.3k | See Footnote | 04/13/2017 |
| 04/17/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 43k | $82.48 | $3.5M | See Footnote | 04/13/2017 |
| 04/13/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 72.3k | $82.39 | $6M | See Footnote | 04/13/2017 |
| 06/01/2016 | Kite Pharma, Inc. | KITE | Grant | Director Stock Option (Right to Buy) | 7k | $50.87 | $356.1k | | 06/01/2016 |
| 06/01/2016 | Kite Pharma, Inc. | KITE | Grant | Common Stock | 2k | $0.00 | $0 | | 06/01/2016 |
| 06/30/2015 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 500 | $63.82 | $31.9k | See Footnote | 06/30/2015 |
| 06/30/2015 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 358.8k | $63.01 | $22.6M | See Footnote | 06/30/2015 |
| 06/30/2015 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 113k | $62.14 | $7M | See Footnote | 06/30/2015 |
| 06/30/2015 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 191.8k | $61.22 | $11.7M | See Footnote | 06/30/2015 |
| 06/09/2015 | Kite Pharma, Inc. | KITE | Grant | Stock Option (Right to Buy) | 10k | $59.23 | $592.3k | | 06/09/2015 |
| 06/25/2014 | Kite Pharma, Inc. | KITE | Conversion | Common Stock | 2.2M | $0.00 | $0 | See Footnote | 06/25/2014 |
| 06/25/2014 | Kite Pharma, Inc. | KITE | Other (acquisition) | Common Stock | 759.2k | $15.30 | $11.6M | See Footnote | 06/25/2014 |
| 06/25/2014 | Kite Pharma, Inc. | KITE | Conversion | Series A Convertible Preferred Stock | 2.2M | $0.00 | $0 | See Footnote | 06/25/2014 |
| 05/14/2014 | TREVENA INC | TRVN | Grant | Stock Option (Right to Buy) | 8.9k | $4.78 | $42.4k | | 05/14/2014 |
| 10/23/2013 | CHIMERIX INC | CMRX | Sale | Common Stock | 447.5k | $15.51 | $6.9M | See footnote | 10/23/2013 |
| 05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Common Stock | 75k | $0.00 | $0 | Alta BioPharma Partners III GmbH & Co. Beteiligungs KG | 05/28/2013 |
| 05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Common Stock | 1.1M | $0.00 | $0 | Alta BioPharma Partners III, L.P. | 05/28/2013 |
| 05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Common Stock | 27.5k | $0.00 | $0 | Alta Embarcadero BioPharma Partners III, LLC | 05/28/2013 |
| 05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series B Preferred Stock | 42.3k | $0.00 | $0 | Alta BioPharma Partners III GmbH & Co. Beteiligungs KG | 05/28/2013 |
| 05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series B Preferred Stock | 629.3k | $0.00 | $0 | Alta BioPharma Partners III, L.P. | 05/28/2013 |
| 05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series B Preferred Stock | 15.5k | $0.00 | $0 | Alta Embarcadero BioPharma Partners III, LLC | 05/28/2013 |
| 05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series C Preferred Stock | 28.3k | $0.00 | $0 | Alta BioPharma Partners III GmbH & Co. Beteiligungs KG | 05/28/2013 |
| 05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series C Preferred Stock | 420.7k | $0.00 | $0 | Alta BioPharma Partners III, L.P. | 05/28/2013 |
|
|